Suministro de la asociación de Pertuzumab (DOE) y Trastuzumab (DOE), Emicizumab (DOE), Faricimab (DOE), Glofitamab (DOE), Obinutuzumab (DOE) y Trastuzumab emtansina (DOE)
Deadline:N/A
Tender information
Araba/Álava
Type
Contract award
Procedure
Negotiated without a call for competition
Ref. number
2026/01089
Estimated value
€122,512,491.18
Duration
5 years
Suministro de la asociación de Pertuzumab (DOE) y Trastuzumab (DOE), Emicizumab (DOE), Faricimab (DOE), Glofitamab (DOE), Obinutuzumab (DOE) y Trastuzumab emtansina (DOE)
1 - L1_ASOCIACIÓN PERTUZUMAB (DOE)/TRASTUZUMAB (DOE)
L1_ASOCIACIÓN PERTUZUMAB (DOE)/TRASTUZUMAB (DOE)
2 - L2_EMICIZUMAB (DOE)
L2_EMICIZUMAB (DOE)
3 - L3_FARICIMAB (DOE)
L3_FARICIMAB (DOE)
4 - L4_GLOFITAMAB (DOE)
L4_GLOFITAMAB (DOE)
5 - L5_OBINUTUZUMAB (DOE)
L5_OBINUTUZUMAB (DOE)
6 - L6_TRASTUZUMAB EMTANSINA (DOE)
L6_TRASTUZUMAB EMTANSINA (DOE)
Buyer
OSAKIDETZA - Servicio Vasco de Salud - Organización Central
Contract award
ROCHE FARMA, S.A. UNIPERSONAL
AwardedDocuments
Contract award
ROCHE FARMA, S.A. UNIPERSONALAwardedBuyer
OSAKIDETZA - Servicio Vasco de Salud - Organización Central
Contract awarded
Important dates
14 Aug - Publication date
Unlock Full Access with Mercell Bidding Business Plus
